NEW YORK (AVAFIN) -- Block trading activities for shares of Pfizer reveal that 285 block trades
were executed during the market session. Trade flow analysis shows that $172,172,222 worth of
shares were bought and $105,119,129 worth of shares were sold by institutional
investors. The positive cash flow $67,053,093 into the stock
shows that investors have bullish sentiment.
View all Block Trading Activities
On the options front, a total of 1,907,487 contracts were traded. Specifically, 1,877,206
call and 30,281 put contracts were traded yielding a 0.02 put/call ratio.
Pfizer is the world's largest pharmaceutical firm, with annual sales near $70 billion. Following the acquisition of Wyeth, prescription drugs now account for close to 90% of sales. Top sellers include cholesterol-lowering Lipitor, Celebrex for arthritis, Viagra for impotence, and Lyrica for epilepsy and some types of neuropathic pain. However, recently approved generic forms of Lipitor will very likely knock off one of Pfizer's key drugs.
PFE is trading above the 50 day moving average and higher
than the 200 day moving average. Shares of Pfizer closed at $27.70, up $0.86 (+3.20%)
in the last trading session. Today's volume of 72M shares is greater than the
average volume of 32M shares.
